secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2026-06-11T20:05:35+00:00
Accession:  0001104659-26-072930
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tvardi stockholders elect directors, approve compensation, and ratify auditor
-----------------------------------------------------------------------------

- Imran Alibhai, Cynthia Smith, and Sujal Shah elected as Class II directors with 3.51M, 3.39M, 3.51M votes for; 2.98M broker non-votes.
- Non-binding advisory vote on executive compensation approved: 3.48M for, 0.16M against, 0.02M abstain.
- Stockholders chose 1-year frequency for future advisory votes on executive compensation (3.45M votes for 1 year).
- Ratification of Deloitte & Touche as independent auditor for FY2026 passed: 6.52M for, 0.06M against, 0.05M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465926072930/0001104659-26-072930-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465926072930/tm2617528d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-072930

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer